You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vilobelimab

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pyoderma Gangrenosum Trial (IFX-1, Placebo)

Not yet recruiting
  • Pyoderma Gangrenosum
  • (no location specified)
Jul 28, 2023

Hidradenitis Suppurativa (HS) Trial in Worldwide (IFX-1, Placebo)

Completed
Has Results
  • Hidradenitis Suppurativa (HS)
  • Birmingham, Alabama
  • +40 more
Mar 15, 2021

SSC Trial in Worldwide (IFX-1, IFX-1 + pembrolizumab combination therapy)

Recruiting
  • SSC
  • IFX-1
  • IFX-1 + pembrolizumab combination therapy
  • La Jolla, California
  • +24 more
Nov 10, 2022

Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) Trial in Worldwide (IFX-1, Placebo-IFX-1, Glucocorticoid

Completed
Has Results
  • Granulomatosis With Polyangiitis (GPA)
  • Microscopic Polyangiitis (MPA)
  • Leuven, Belgium
  • +75 more
Aug 3, 2022

Severe Sepsis, Septic Shock Trial in Germany (CaCP29, Placebo)

Completed
  • Severe Sepsis
  • Septic Shock
  • CaCP29
  • Placebo
  • Aachen, Germany
  • +10 more
Apr 22, 2016